BEGIN:VCALENDAR VERSION:2.0 PRODID:Linklings LLC BEGIN:VTIMEZONE TZID:Asia/Seoul X-LIC-LOCATION:Asia/Seoul BEGIN:STANDARD TZOFFSETFROM:+0900 TZOFFSETTO:+0900 TZNAME:KST DTSTART:18871231T000000 DTSTART:19881009T020000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTAMP:20230103T035307Z LOCATION:Room 315\, Level 3\, West Wing DTSTART;TZID=Asia/Seoul:20221206T130000 DTEND;TZID=Asia/Seoul:20221206T180000 UID:siggraphasia_SIGGRAPH Asia 2022_sess206_caf_314@linklings.com SUMMARY:CAR-T Cells: Engineered Cancer Killers DESCRIPTION:Computer Animation Festival\n\nCAR-T Cells: Engineered Cancer Killers\n\nDivjak, Ramsbottom, Rudd-Schmidt, Fedele, Granger...\n\nThis wo rk was created to show how Chimeric Antigen Receptor T-Cell (CAR-T) techno logy supercharges a patient's own immune cells to combat the processes can cer cells use to hide from our immune system. This revolutionary treatment is now offered to some blood cancer patients at the Peter McCallum Cancer Centre, so we recognised a need for detailed explanation. Doing so at the molecular level highlights the elegance of the Chimeric Antigen Receptor structures (CARs) and also the complexity of our inner cellular world, whi ch most of us are completely unaware of. Unfortunately, control of this in ner world can sometimes go awry, leading to cancer. \n\nThis is the first time CARs have been accurately constructed and animated at the molecular l evel. No structural data were available, so CARs were assembled by inferri ng the protein sequences from available DNA sequences and then searching d atabases for protein matches. To date, only simple, conceptual animations explaining CAR-T therapy are available, which in our opinion fail to highl ight the technology as a ground-breaking re-engineering of human immune st ructures, that seek and destroy cancer cells. Also included is trailblazin g time-lapse microscopy footage of live immune cells and CAR-T cells in ac tion in the laboratory. These unique sequences provide a window into the l iving human immune system, showing how CAR-T cells kill cancer cells in a specific, aggressive way. \n\nThe production is designed for a general aud ience, to explain this radical technology for treatment of cancer and to i nspire confidence in cancer patients considering it as therapy. However, t he scientific accuracy of the production also makes it suitable for presen tation at scientific meetings and conferences and can also be used to educ ate and train those with a science or medical background. The production t herefore has universal application for education, training and engagement with this emerging cancer treatment paradigm.\n\nRegistration Category: FU LL ACCESS, EXPERIENCE PLUS ACCESS, TRADE EXHIBITOR\n\nFormat: IN-PERSON URL:https://sa2022.siggraph.org/en/full-program/?id=caf_314&sess=sess206 END:VEVENT END:VCALENDAR